Mediware Grows Home Care Business Through Software Acquisition

Home care software provider Mediware Information Systems this week announced it has acquired Definitive Homecare Solutions Ltd. known for its CPR+ flagship software. 

Lenexa, Kansas-based Mediware will acquire more than 600 new customers as well as the expertise, products, services and contracts of DHS, which serves home infusion, home medical equipment and retail and sub-acute speciality pharmacy sectors. 

The shift to home-based care settings is driving the market for home care acquisitions, Mediware’s executives said. 

“Market conditions are ripe for consolidation in the homecare technology sector as care shifts to home-based settings,” said Thomas Mann, Mediware president and chief executive officer.

The company cited health reform, aging populations, prevalence of chronic disease and other factors as driving home care growth as well as the potential for consolidation. 

“Mediware Alternate Care Solutions has built a solid reputation for powerful products and smart subject matter experts, and acquiring DHS deepens our expertise in homecare even more,” Mann said. “DHS is a forward-thinking company that shares Mediware’s vision for delivering homecare technology with advanced functionality and interoperability. We’re very excited to welcome CPR+ to the Mediware family of solutions.”

Terms of the deal were not disclosed. 

Written by Elizabeth Ecker

Elizabeth Ecker on EmailElizabeth Ecker on Linkedin
Elizabeth Ecker
Director of Content at Home Health Care News
Curious about all things, when not writing about senior housing topics, Liz is an avid explorer of food. She loves trying new recipes, new restaurants and new ice cream flavors. (Current favorite: Goat cheese with red cherries.)

By continuing to use the site, you agree to the use of cookies. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy